Difference between revisions of "Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2) (Q10987)"
Jump to navigation
Jump to search
(Removed claim: named entity (P78): COVID-19 (disease - MeSH supplementary concept) (Q7804)) |
|||
| (One intermediate revision by the same user not shown) | |||
| Property / named entity | |||
| - | |||
| Property / named entity: COVID-19 (disease - MeSH supplementary concept) / rank | |||
| - | |||
| Property / Collection or Dataset of Origin | |||
| + | |||
| Property / Collection or Dataset of Origin: Pubtator Central BioC-JSON formatted article files / rank | |||
| + | Normal rank | ||
Latest revision as of 23:39, 20 October 2020
Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2)
|
Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2
|
Statements
0 references
0 references
0 references
